Does the course of laboratory parameters help us to predict the outcome of CCHF?

Turkish Journal of Medical Sciences

Volumn 46, Issue 2, 2016, Pages 328-334

  Kazancioğlu, Sümeyye ^a   Akinci, Esragül ^b   Baştuğ, Aliye ^b   Kayaaslan, Bircan ^c   But, Ayşe ^b   Aslaner, Halide ^b   Eren, Selim Sırrı ^b   Yetkin, Meltem Arzu ^b   Bodur, Hurrem ^b  

^a Niksar State Hospital   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c YILDIRIM BEYAZIT UNIVERSITY   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever; Mortality; Severity criteria

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; LACTATE DEHYDROGENASE;

ADULT; ARTICLE; BLEEDING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE SPECIFIC SURVIVAL; FATALITY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; UREA BLOOD LEVEL; VIRUS LOAD; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; HOSPITALIZATION; PROGNOSIS;

HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HOSPITALIZATION; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROGNOSIS;

EID: 84958525720     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1408-89     Document Type: Article

References (17)

1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res 2004; 64: 145-160.
2. Appannanavar SB, Mishra B. An update on Crimean Congo hemorrhagic fever. J Glob Infect Dis 2011; 3: 285-292.
3. Yilmaz GR, Buzgan T, Irmak H, Safran A, Uzun R, Cevik MA, Torunoglu MA. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis 2009; 13: 380-386.
4. Bodur H, Akinci E, Ascioglu S, Öngürü P, Uyar Y. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis 2012; 18: 640-642.
5. Jamil B, Hasan RS, Sarwari AR, Burton J, Hewson R, Clegg C. Crimean-Congo hemorrhagic fever: experience at a tertiary care hospital in Karachi, Pakistan. T Roy Soc Trop Med H 2005; 99: 577-584.
6. Akinci E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector-Borne Zoonot 2013; 13: 429-437.
7. Leblebicioglu H. Crimean-Congo hemorrhagic fever in Eurasia. Int J Antimicrob Ag 2010; 36: S43-S46.
8. Çevik MA, Erbay A, Bodur H, Gülderen E, Baştuğ A, Kubar A, Akıncı E. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008; 12: 374-379.
9. Akyol M, Özçelik S, Engin A, Hayta SB, Biçici F. Cutaneous manifestations of Crimean-Congo haemorrhagic fever: morbilliform eruptions may reflect a favorable outcome and not low platelet levels. Eur J Dermatol 2010; 20: 523-524.
10. Sannikova IV, Pacechnikov VD, Maleev VV. Respiratory lesions in Crimean-Congo hemorrhagic fever. Ter Arkh 2007; 79: 20-23 (in Russian with abstract in English).
11. Dogan OT, Engin A, Salk I, Epozturk K, Eren SH, Elaldi N, Bakir M, Dokmetas I, Akkurt I. Evaluation of respiratory findings in Crimean-Congo hemorrhagic fever. SE Asian J Trop Med 2011; 42: 1100-1105.
12. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Com S, Uyar Y, Carhan A, Ozkaya E, Ertek M et al. A preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March-June 2008. Eurosurveillance 2008; 14: 18953.
13. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989; 11: 794-800.
14. Hatipoglu CA, Bulut C, Yetkin MA, Ertem GT, Erdinc FS, Kilic EK, Sari T, Kinikli S, Oral B, Demiroz AP et al. Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey. Scand J Infect Dis 2010; 42: 516-521.
15. Ozturk B, Tutuncu E, Kuscu F, Gurbuz Y, Sencan I, Tuzun H. Evaluation of factors predictive of the prognosis in Crimean-Congo hemorrhagic fever: new suggestions. Int J Infect Dis 2012; 16: e89-e93.
16. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 2010; 47: 361-365.
17. Cevik MA, Erbay A, Bodur H, Eren SS, Akinci E, Sener K, Ongürü P, Kubar A. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 2007; 45: e96-e10.